Last Updated: June 06, 2018
Breast cancer occurs when cells in the breast multiply out of control, forming an abnormal mass (tumor) that tends to invade surrounding tissues. Because cancer cells grow destructively, they are also called malignant.
The most common breast cancer, ductal carcinoma, starts in the lactiferous ducts that transport breast milk to the nipple. Another type, lobular carcinoma, starts in the mammary gland lobules that produce milk.
Carcinoma in situ (CIS) is the term used for a small, early cancer that does not involve surrounding tissues. Invasive breast cancer is larger and spreads to lymphatic vessels and lymph nodes under the arm (axillary lymph nodes). The worst form, metastatic cancer, spreads to other parts of the body.
Breast cancer is diagnosed in 1 in 8 women in the United States with most cases occurring in women over age 50. Breast cancer is the second leading cause of cancer death in women, following lung cancer. Rarely, this disease can occur in men.
Female hormones, estrogen and progesterone, stimulate the growth of breast cancer. Many of the identified risk factors for breast cancer are related to a person’s exposure to these hormones.
Some breast cancers are linked to inherited defects (mutations) in certain genes. BRCA1 and BRCA2 are two genes associated with hereditary breast and ovarian cancer. DNA health testing can help you determine if you are at genetically higher risk of breast cancer due to BRCA1 and BRCA2.
A female’s age at menarche (first period), age at menopause, and reproductive history are important because women with a greater number of menstrual cycles over their lifetime have a higher exposure to estrogen.
The typical symptoms of breast cancer include:
The diagnosis of breast cancer is based on the patient’s symptoms, physical exam, and test results.
When breast cancer is diagnosed, the physician first determines the extent (stage) of the disease. The stage (based on the status of the lymph nodes, tumor size, and any spread to distant sites) determines the course of treatment and likelihood of survival.
For staging purposes, a computed tomography is performed to provide detailed images of the breast. A bone scan is obtained to check for spread of cancer to the bones. Positron emission tomography (PET) scan also detects the spread of cancer. The status of the lymph nodes is determined when biopsies are performed during surgery.
Following lumpectomy, the chest is often treated with radiation to destroy remaining cancer cells and prevent a recurrence of cancer. Radiation is sometimes used after mastectomy as well.
Chemotherapy is prescribed when cancer involves the lymph nodes. These medications may be administered after surgery to destroy unseen cancer cells remaining in the body. Sometimes chemotherapy is given before surgery to shrink large tumors and facilitate their removal with surgery.
Most breast cancers are hormone receptor positive (carrying receptors for estrogen and progesterone). Certain drugs, selective estrogen receptor modulator (SERM) medications, block the action of estrogen and inhibit breast cancer growth. Other medications work by lowering estrogen levels in the body.
Some breast cancers produce large amounts of a protein called human growth factor receptor 2 (HER2). Several medications are designed to target these types of cancers.
Exercise and activities like yoga or tai chi are often recommended to reduce stress.
There is a lower incidence of breast cancer in countries where the diet is low in fat; therefore, a low-fat diet and normal body weight may be preventative. Additionally, avoidance or limited use of alcohol lowers the risk for this disease.
Studies show that moderate to vigorous exercise significantly lowers the risk of breast cancer. There is still debate over how much exercise is needed.
Genetic testing for mutations in BRCA1 and BRCA2 genes is an option for women with multiple family members with breast or ovarian cancer. Women at very high risk may receive prophylactic medications or opt for prophylactic double mastectomy to reduce their risk of developing breast cancer.
To detect cancer before there are any symptoms, screening consists of a triad of breast self-examination, clinical breast examination by a health care professional, and screening mammography. Physicians recommend that women 20 years and older perform monthly breast self-examinations. Women in their 20s and 30s should receive a clinical breast examination by a health care professional at least every three years. Over age 40, women should receive a clinical breast examination every year. For women age 40 and older, an annual screening mammogram is recommended.